GlaxoSmithKline Pharmaceuticals Limited informed that considering his long tenure on the Company's Board and due to other personal commitments, Mr. Nihal Kaviratne (Din:00032473) has voluntarily relinquished his position as Board member with effect from closing hours of 26th July, 2022. He has confirmed that there are no other material reasons other than provided in the resignation letter. Further Mr. Nihal Kaviratne is not holding Directorship/Committee membership in any listed entities in India.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,430 INR | -1.78% | +6.06% | +28.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.09% | 4.96B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithkline Pharmaceuticals Limited Announces Nihal Kaviratne Voluntarily Relinquished as Board Member, Effective July 26, 2022